Molecular steps of cell suicide: An insight into immune senescence

Journal of Clinical Immunology

Volumn 20, Issue 4, 2000, Pages 229-239

  Gupta, S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aging; Apoptosis; Fas; Fas ligand; Mitochondria; TNF receptor

Indexed keywords

CASPASE; FAS ANTIGEN; TUMOR NECROSIS FACTOR RECEPTOR;

AGING; ANIMAL CELL; APOPTOSIS; CELL DEATH; EMBRYO DEVELOPMENT; ENZYME INHIBITION; GENE DELETION; KILLER CELL; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; REVIEW; SENESCENCE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ADULT; AGED; AGED, 80 AND OVER; AGING; ANIMALS; ANTIGENS, CD95; APOPTOSIS; ARABIDOPSIS PROTEINS; BACTERIAL PROTEINS; CASPASES; CELL AGING; CYSTEINE PROTEINASE INHIBITORS; CYTOCHROME C GROUP; ELECTRON TRANSPORT; ENZYME ACTIVATION; FAS LIGAND PROTEIN; FATTY ACID DESATURASES; HUMANS; IMMUNE SYSTEM; INHIBITOR OF APOPTOSIS PROTEINS; INSECT PROTEINS; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; MITOCHONDRIA; PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, TUMOR NECROSIS FACTOR; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033853735     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006653917314     Document Type: Review

References (138)

1. Effect of age on cytotoxic T lymphocyte memory as well as serum and local antibody responses elicited by inactivated influenza virus vaccine
2. Cellular determinants of age-related decrements in the T-cell mitogen response of B6CBAF1 mice
3. Splenic and inguinal lymph node T cells of aged mice respond differently to polyclonal and antigen-specific stimuli
4. Comparison of CD3 and CD2 activation pathways in T cells from young and elderly adults
5. The effect of influenza vaccination on IL-2 production in healthy elderly: Implications for current vaccination practices
6. + T cells correlates with shifts in the frequencies of cell subsets defined by membrane CD44, CD45RB, 3G11, and MEL-14 expression
7. Interleukin-6: A cytokine for gerontologists
8. IgE regulation and lymphokine patterns in aging humans
9. Natural regulators of T-cell lymphokine production in vivo
10. L-selectin expression differentiates T cells isolated from different lymphoid tissues in cattle but does not correlate with memory
11. T cell differentiation and functional maturation in aging mice
12. Differential tyrosine-specific protein phosphorylation in mouse T lymphocyte subsets. Effect of age
13. The cellular and subcellular basis of immunosenescence
14. Immunodeficiency of the elderly
15. The aging immune system: Primers and prospectus
16. Age-associated changes in mitogen-induced protein phosphorylation in murine T lymphocytes
17. Membrane signal transduction in T cell in aging humans
18. Age-related impairment of early and late events of signal transduction in mouse immune cells
19. An age-related decrease in rescue from T cell death following costimulation mediated by CD28
20. Early steps in T cell development are affected by aging
21. Programmed cell death (apoptosis) and cell survival regulation: Relevance to AIDS and cancer
22. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis
23. High expression of Apo-1 (CD95) on T lymphocytes from human immunodeficiency virus-1-infected children
24. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome
25. Death receptors: Signaling and modulation
26. Mitochondria and apoptosis
27. Molecular and biochemical pathways of apoptosis in lymphocytes from aging humans
28. Pathways of apoptosis in lymphocyes from aging humans
29. The Fas death factor
30. Role of Fas-mediated cell death in the regulation of immune responses
31. Generalized lymphoproliferative disease in mice caused by a point mutation in the Fas ligand
32. Missense mutations in the Fas gene resulting in autoimmune lymphoproliferative syndrome: A molecular and immunological analysis
33. Characterization of human Fas gene. Exon/intron and promoter region
34. Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternate splicing
35. A naturally occurring soluble isoform of murine Fas generated by alternating splicing
36. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family
37. Fas ligand in human serum
38. Fas ligand, death gene
39. Two CD95 (Apo-1/Fas) signaling pathways
40. I-Flice, a novel inhibitor of tumor necrosis factor receptor-1 and CD95-induced apoptosis
41. Inhibition of death receptor signals by cellular FLIP
42. Immune functions of tumor necrosis factor
43. Tumor necrosis factor receptor - Structure and function
44. Two TNF receptors
45. Two tumor necrosis factor receptors: Structure and function
46. Tumor necrosis factor-mediated signaling pathways
47. Identification of a 60-kDa tumor necrosis factor (TNF) receptor as the major signal transducing component in TNF responses
48. Tumor necrosis factor (TNF) receptor expression in T lymphocytes: Differential regulation of the type I receptor during activation of resting and effector T cells
49. Suicide by order: Some open questions about the cell-killing activities of the TNF ligand and receptor families
50. TNF-induced signaling in apoptosis
51. Cell death induction by receptors of the TNF family: Towards a molecular understanding
52. Early events in TNF signaling: A story of associations and dissociations
53. Transducing signals of life and death
54. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins
55. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways
56. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex
57. The CED-3/ICE-like protease Mch2 is activated during apoptosis and cleaves the death substrate lamin A
58. MAP3K-related kinase involved in NF-kappa-B induction by TNF, CD95 and IL-1
59. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappa-B activation prevents cell death
60. I-κb: A specific inhibitor of NF-κB transcription factor
61. Function and activation of NF-κB in the immune system
62. The NF-kappa B proteins: New discoveries and insights
63. NF-kappa B controls expression of inhibitor I kappa B alpha: Evidence for an inducible autoregulatory pathway
64. Rapid proteolysis of I kappa-alpha is necessary for activation of transcription factor NF-kappa B
65. Tumor necrosis factor: Pleiotropic cytokine
66. Tumor necrosis factors: Developments during the last decade
67. An essential role for NF-κB in preventing TNF-α-induced cell death
68. TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB
69. Suppression of TNF-α-induced apoptosis by NF-κB
70. Prevention of constitutive TNF receptor 1 signaling by silencer of death domains
71. Endogenous inhibitors of caspases
72. Proteases to die for
73. Caspases: Intracellular signaling by proteolysis
74. Cytochrome c: Can't live with, it can't live without it
75. Involvement of CPP32/Yama(-like) proteases in Fas-mediated apoptosis
76. The large subunit of the DNA replication complex C (DSEB/RF-C140) cleaved and inactivated by caspase-3 (CPP32/YAMA) during Fas-induced apoptosis
77. CPP32, a novel apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta converting enzyme
78. Inhibition of Caenorhabiditis elegans cell death protease CED-3 by a CED-3 cleavage site in baculovirus p35 protein
79. Identification and inhibition of ICE/CED-3 protease necessary for mammalian apoptosis
80. Yama/CPP32 beta, a mammalian homolog of CED-3, is a Crm-A-inhibitable protease that cleaves the death substrate poly (ADP-ribose) polymerase
81. Cleavage of lamin A by Mch2 alpha but not CPP32: Multiple interleukin 1 beta-converting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis
82. Bcl-2 prevents CD95 (Fas/APO-1)-induced degradation of lamin B and poly(ADP-ribose) polymerase and restores the NF-kappa-B signaling pathway
83. The DNA-dependent protein kinase catalytic subunit (p460) is cleaved during Fas-mediated apoptosis in Jurkat cells
84. Caspase-3-mediated cleavage of protein kinase C theta in induction of apoptosis
85. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis
86. A caspase-activated DNAse that degrades DNA during apoptosis and its inhibitor ICAD
87. The Ced-4 homologous protein FLASH is involved in Fas-mediated activation of caspase-8 during apoptosis
88. The Bcl-2 protein family: Arbiters of cell survival
89. The Bcl-2 family of proteins: Regulators of cell death and survival
90. Mitochondria and apoptosis: HQ or high-security prison
91. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
92. Regulation of apoptosis by Bcl-2 family proteins and its role in cancer and chemoresistance
93. Bcl-x and Bcl-2 inhibit TNF- and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells
94. Bcl-x, a Bcl-2 related gene that functions as a dominant regulator of apoptotic cell death
95. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax
96. Checkpoints of dueling dimers foil death wishes
97. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death
98. Induction of genes during apoptosis: Examples from the immune system
99. Role of mitochondria and C-terminal membrane anchor of Bcl-2 in Bax induced growth arrest and mortality in Saccharomyces cerevisiae
100. Cell-free apoptosis in Xenopus egg extracts: Inhibition by Bcl-2 and requirement for an organelle fraction enriched in mitochondria
101. Reactive oxygen species, mitochondria, apoptosis and aging
102. Implication of mitochondria in apoptosis
103. The central executioner of apoptosis: Multiple connections between protease activation and mitochondria in Fas/APO-1/CD95- and ceramide-induced apoptosis
104. Role of proteolysis in apoptosis: Involvement of serine proteases in internucleosomal DNA fragmentation in immature thymocytes
105. Mitochondrial permeability transition triggers lymphocyte apoptosis
106. The proto-oncogene Bcl-2 and its role in regulating apoptosis
107. Tumor necrosis factor-α induces superoxide anion production in mitochondria of L929 cells
108. Commitment to apoptosis is associated with changes in mitochondrial biogenesis and activity in SV40 conditional cell lines
109. Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c
110. Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked
111. The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis
112. The overexpression of Bax produces cell death upon induction of the mitochondrial permeability transition
113. Bax directly induces release of cytochrome c from isolated mitochondria
114. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis
115. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors
116. Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis
117. X-linked IAP is a direct inhibitor of cell-death proteases
118. NF-κB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation
119. Anti-CD3-induced apoptosis in T cells from young and old mice
120. Prevention of age-related T cell apoptosis defect in CD2-fas-transgenic mice
121. Excessive apoptosis of mature T lymphocytes is a characteristic feature of human immune senescence
122. Susceptibility to apoptosis of T lymphocytes from elderly humans is associated with increased in vivo expression of functional Fas receptors
123. Increased apoptosis of CD45RO-T cells with aging
124. Regulation of CD95 (Apo-1) expression and the induction of apoptosis in human T cells: Changes in old age
125. Increased apoptosis of T cell subsets in aging humans: Altered expression of Fas (CD95), Bcl-2 and Bax
126. Induction of apoptosis in mature T cells by tumor necrosis factor
127. Differential expression of apoptosis related Fas antigen on lymphocyte subpopulations in human peripheral blood
128. + lymphocytes in the aged microenvironment results in a memory-enriched population
129. + T cells, CD8+ T cells and monocytes
130. Apoptosis regulated by a death factor and its receptor: Fas ligand and Fas
131. Increased activity of caspase-3 and caspase-8 during Fas-mediated apoptosis in lymphocytes from ageing humans
132. The production of TNF, IL-1 and IL-6 in cutaneous tissues during maturation and aging
133. Higher production of TNF elicited by a biological response modifier in aging mice
134. Increased TNF-α-induced apoptosis in lymphocytes from aged humans. Changes in the expression of TNF-α receptors and activation of caspases
135. Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes and neutrophils
136. Inverse expression of Bcl-2 protein and Fas antigen in lymphoblasts in peripheral nodes and activated peripheral blood T and B lymphocytes
137. Bcl-2 and Fas/Apo-1 regulate distinct pathways to lymphocyte apoptosis
138. Resistance to APO-1 (CD95)-induced apoptosis in T-ALL is determined by a Bcl-2 independent anti-apoptotic program